Cargando…

Bone marrow endothelial cell-derived interleukin-4 contributes to thrombocytopenia in acute myeloid leukemia

Normal hematopoiesis can be disrupted by the leukemic bone marrow microenvironment, which leads to cytopenia-associated symptoms including anemia, hemorrhage and infection. Thrombocytopenia is a major and sometimes fatal complication in patients with acute leukemia. However, the mechanisms underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Ai, Gong, Yuemin, Zhu, Caiying, Yang, Wanzhu, Li, Qing, Zhao, Mei, Ma, Shihui, Li, Jianyong, Hao, Sha, Cheng, Hui, Cheng, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886411/ https://www.ncbi.nlm.nih.gov/pubmed/30792200 http://dx.doi.org/10.3324/haematol.2018.214593

Ejemplares similares

Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras
Publicado: (1993)

Interlukin-4 weakens resistance to stress injury and megakaryocytic differentiation of hematopoietic stem cells by inhibiting Psmd13 expression
por: Gao, Ai, et al.
Publicado: (2023)

The immunometabolic landscape of the bone marrow microenvironment in acute myeloid leukemia
por: Xu, Binyan, et al.
Publicado: (2022)

Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?
por: Barak, Avital F., et al.
Publicado: (2011)

Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia
por: Nakamura, Yuichi, et al.
Publicado: (2022)

Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid Leukemia
por: Cheng, Cheng, et al.
Publicado: (2021)

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
por: Yao, Yiyi, et al.
Publicado: (2021)

Differential regulation of myeloid leukemias by the bone marrow microenvironment
por: Krause, Daniela S., et al.
Publicado: (2013)

The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia
por: Pimenta, Débora Bifano, et al.
Publicado: (2021)

Contribution of interleukin 27 serum level to pathogenesis and prognosis in children with immune thrombocytopenia
por: Hassan, Tamer, et al.
Publicado: (2022)

Role of the bone marrow vascular niche in chemotherapy for MLL-AF9-induced acute myeloid leukemia
por: Xu, Chang, et al.
Publicado: (2023)

Bone marrow–confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia
por: Mei, Yang, et al.
Publicado: (2022)

Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia
por: Passaro, Diana, et al.
Publicado: (2017)

Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines
por: Silla, Lucia Mariano da Rocha, et al.
Publicado: (2013)

Study of Bone Marrow Lymphocyte Subset in Acute Myeloid Leukemia
por: Dange, Prasad, et al.
Publicado: (2021)

Increased number of mast cells in the bone marrow of chronic myeloid leukemia may herald the pending myeloid transformation—the mast cell is an indicator of myeloid transformation
por: Xu, Peipei, et al.
Publicado: (2019)

Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia
por: Liu, Yan, et al.
Publicado: (2022)

Endothelial activation and dysfunction in severe fever with thrombocytopenia syndrome
por: Li, Xiao-Kun, et al.
Publicado: (2017)

Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia
por: Zhan, Yanxia, et al.
Publicado: (2021)

P773: CYCLOPHOSPHAMIDE COMBINED WITH PREDNISONE FOR CYCLOSPORINE-REFRACTORY/RELAPSED T-LARGE GRANULAR LYMPHOCYTE LEUKEMIA ASSOCIATED PURE RED CELL APLASIA
por: Liu, Xiaoqing, et al.
Publicado: (2023)

Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model
por: Yang, Liu, et al.
Publicado: (2021)

Epigenetic silencing of UBXN8 contributes to leukemogenesis in t(8;21) acute myeloid leukemia
por: Yang, Erna, et al.
Publicado: (2021)

Dependence of Acute Myeloid Leukemia on Adhesion within the Bone Marrow Microenvironment
por: Becker, Pamela S.
Publicado: (2012)

Treatment of Acute Myeloid Leukemia with 20–30% Bone Marrow Blasts
por: Maurillo, Luca, et al.
Publicado: (2013)

Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia
por: Mukaida, Naofumi, et al.
Publicado: (2017)

Effect of Imatinib on Bone Marrow Morphology and Angiogenesis in Chronic Myeloid Leukemia
por: Pandey, Neetu, et al.
Publicado: (2019)

Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs
por: Moussa Agha, Douâa, et al.
Publicado: (2020)

Bone marrow metastasis of glioblastoma multiforme mimicking acute myeloid leukemia
por: Nagata, Akihito, et al.
Publicado: (2020)

Acute myeloid leukemia shapes the bone marrow stromal niche in vivo
por: Pievani, Alice, et al.
Publicado: (2020)

Charcot-Leiden Crystals in Acute Myeloid Leukemia with Bone Marrow Necrosis
por: Yeldir, Neşe, et al.
Publicado: (2023)

TRIM25 contributes to the malignancy of acute myeloid leukemia and is negatively regulated by microRNA-137
por: Wang, Sheng, et al.
Publicado: (2020)

VSTM-v1, a potential myeloid differentiation antigen that is downregulated in bone marrow cells from myeloid leukemia patients
por: Xie, Min, et al.
Publicado: (2015)

Fumarate hydratase deficiency induces chronic myeloid leukemia progression
por: Li, Shan, et al.
Publicado: (2019)

Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia
por: Cui, Yao-Li, et al.
Publicado: (2016)

Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration
por: Oyama, Takashi, et al.
Publicado: (2023)

Interleukin-27 and interleukin-35 in de novo acute myeloid leukemia: expression and significance as biological markers
por: Ahmed, Heba A, et al.
Publicado: (2019)

FOXM1 contributes to treatment failure in acute myeloid leukemia
por: Khan, Irum, et al.
Publicado: (2018)

Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia
por: Chen, Runzhe, et al.
Publicado: (2015)

The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis
por: Shoukier, Mahran, et al.
Publicado: (2020)

Resveratrol Downregulates Interleukin-6-Stimulated Sonic Hedgehog Signaling in Human Acute Myeloid Leukemia
por: Su, Yu-Chieh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ibvrbdq4uj7flffq0pbnuj1lga